Sjögren's syndrome and mean platelet volume von Tezcan, M E, Demir, Ş, Sargın, M, Aliustaoğlu, M, Göker, B

Volltext

CP-063 Assessment of urinary 8-hydroxydeoxyguanosine level in diabetic cancer patients von Al-taie, A, Izzettin, F, Sancar, M, Köseoglu, A, Aliustaoğlu, M, Kaptanağasi, A

Volltext

The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival von Oven Ustaalioglu, B. B., Balvan, O., Bilici, A., Develi, A., Aliustaoglu, M., Vardar, F. A., Erkol, B.

Volltext

1619 Low molecular weight heparin (LMWH) treatment in cancer patients with low risk venous thromboembolism - results of Turkish Observational Study (TREBECA) von Ozkan, M, Cicin, I, Ozaslan, E, Benekli, M, Oksuzoglu, B, Kocer, M, Isýkdogan, A, Sevinc, A, Karaoglu, A, Dane, F, Cubukcu, E, Elkiran, E.T, Aliustaoglu, M

Volltext

Prognostic importance of RASSF2 expression in patients with gastric cancer who had undergone radical gastrectomy von Aydin, D., Bilici, A., Kayahan, S., Yavuzer, D., Basar, M., Aliustaoglu, M.

Volltext

Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy von Aydin, D., Bilici, A., Yavuzer, D., Kefeli, U., Tan, A., Ercelep, O., Mert, A., Yuksel, S., Ozcelik, M., Isik, D., Surmeli, H., Odabasi, H., Aliustaoglu, M.

Volltext

The efficacy and safety of capecitabine plus bevacizumab combination as first-line treatment in elderly metastatic colorectal cancer patients von Ozcelik, M., Odabas, H., Ercelep, O., Yuksel, S., Mert, A. G., Aydin, D., Surmeli, H., Isik, D., Isik, S., Oyman, A., Oven Ustaalioglu, B. B., Aliustaoglu, M., Gumus, M.

Volltext

Safety and efficacy of transdermal fentanyl in patients with cancer pain: phase IV, Turkish oncology group trial von KÖMÜRCÜ, Ş., TURHAL, S., ALTUNDAĞ, K., ATAHAN, L., TURNA, H.S., MANAVOĞLU, O., YAVUZ, A.A., ÖZKÖK, S., ALIUSTAOĞLU, M., ALTINBAŞ, M., PAK, Y., COOPER, R., YAYLACI, M., DEMIRKAN, B., SARIHAN, S., ÖZDEMIR, F.

Volltext

Abstract P3-01-21: Is lymph node ratio (LNR) having additional contribution for predict prognosis on pathologic lymph node staging in node-positive breast cancer patients? von Kaplan, MA, Odabasi, H, Ozdemir, N, Harputluoglu, H, Aliustaoglu, M, Berk, V, Gunaydin, Y, Uncu, D, Elkiran, T, Aydin, D, Isikdogan, A

Volltext

6570 The effect of peripheral blood values before treatment on prognosis of patients with locally advanced gastric cancer von Aliustaoglu, M, Bilici, A, Ustaalioglu, B.B.O, Konya, V, Gucun, M, Seker, M, Gumus, M

Volltext

The absence of early diarrhea with atropine premedication during irinotecan therapy in metastatic colorectal patients von Yumuk, P F, Aydin, S Z, Dane, F, Gumus, M, Ekenel, M, Aliustaoglu, M, Karamanoglu, A, Sengoz, M, Turhal, S N

Volltext

1204PTHREE DIFFERENT CHEMOTHERAPY COMBINATIONS WITH CONCURRENT THORACIC RADIATION FOR PATIENTS WITH STAGE III NON-SMALL CELL LUNG CANCER von Ozcelik, M., Ercelep, O. Balvan, Mert, A. Guven, Yuksel, S., Ozdemir, P., Surmeli, H., Isık, D., Aydin, D., Korkmaz, T., Odabas, H., Aliustaoglu, M., Gemici, C., Mayadagli, A., Gumus, M.

Volltext

Three Different Chemotherapy Combinations with Concurrent Thoracic Radiation for Patients with Stage III Non-Small Cell Lung Cancer von Ozcelik, M., Ercelep, O. Balvan, Mert, A. Guven, Yuksel, S., Ozdemir, P., Surmeli, H., Isık, D., Aydin, D., Korkmaz, T., Odabas, H., Aliustaoglu, M., Gemici, C., Mayadagli, A., Gumus, M.

Volltext

Evaluation of expression of ERCC1 in hepatocellular cancer von Bas, E., Turhal, N. S., Er, O., Aliustaoglu, M., Seber, S., Dane, F., Korkmaz, T., Soyuer, I., Ozkara, S., Celikel, C.

Volltext

Single-center experiences of neoadjuvant systemic therapy in breast cancer: Individualization of the treatment von Gumus, M., Ustaalioglu, B. O., Seker, M., Bilici, A., Salman, T., Sönmez, B., Aliustaoglu, M., Eser, M., Salepci, T., Yaylaci, M.

Volltext

The changing pattern of risk factors and disease characteristics of breast cancer in Turkey: A cross-sectional study of a Turkish oncology group (BREASTTURK) von Akbulut, H., Altundag, M. K., Saip, P., Coskun, H. S., Camci, C., Ozkan, M., Paydas, S., Zengin, N., Alco, G., Aliustaoglu, M., Basaran, G., Yamac, D., Yucel, I., Goker, E., Yaman, E., Isikdogan, A., Ozisik, Y. Y., Topuz, E., Ozdogan, M., Icli, F.

Volltext

Epirubicin, cisplatin, oral UFT (ECU) combination chemotherapy in metastatic gastric carcinoma von Kaya, S., Aliustaoglu, M., Dane, F., Gumus, M., Seker, M., Ozturk, A., Salepci, T., Yaylaci, M., Mayadagli, A.

Volltext

Outcome of non small cell lung carcinoma patients receiving chemotherapy in Kartal State Hospital, Turkey von Kocak, M., Mayadagli, A., Ozkan, A., Gumus, M., Marti, A., Demir, O., Parlak, C., Aliustaoglu, M.

Volltext

The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy von Bilici, Ahmet, MD, Salman, Tarik, MD, Oven Ustaalioglu, Bala Basak, MD, Unek, Tugba, MD, Seker, Mesut, MD, Aliustaoglu, Mehmet, MD, Gezen, Cem, MD, Unek, Tarkan, MD, Yavuzer, Dilek, MD, Unlu, Mehtat, MD, Gumus, Mahmut, MD, Yilmaz, Ugur, MD

Volltext

What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? von Gumus, Mahmut, Yumuk, Perran Fulden, Atalay, Gul, Aliustaoglu, Mehmet, Macunluoglu, Beyza, Dane, Faysal, Caglar, Hale, Sengoz, Meric, Turhal, Serdar

Volltext